Mokhtari M, Tafani J A, Zajac J M
Laboratoire de Pharmacologie et de Toxicologie, CNRS, Toulouse, France.
Neuropeptides. 1993 Sep;25(3):183-91. doi: 10.1016/0143-4179(93)90101-f.
The in vivo binding properties of cerebral opioid receptors were investigated in mice after intracerebroventricular (i.c.v.) injections of iodinated FK33-824 and [D.Ala2]deltorphin-I which behave in vitro as highly selective ligands possessing high affinity for mu and delta receptors, respectively. [125I]FK33-824 and [125I][D.Ala2] deltorphin-I exhibited similar diffusion kinetics after i.c.v. injection and bound specifically to sites characterized pharmacologically as mu and delta receptors respectively. Autoradiographic analysis revealed that after i.c.v. administration, concentrations of [125I]FK33-824 and [125I][D.Ala2]deltorphin-I remained higher in the circumventricular than in the deep structure of the brain and that specific sites labelled in vivo were differently distributed from those observed after in vitro labelling. FK33-824 was 250 times more analgesic than [D.Ala2]deltorphin-I in the tail-flick test and at doses producing a similar analgesia, [D.Ala2]deltorphin-I occupied a high proportion of mu receptors. Furthermore, analgesic effect of [D.Ala2]deltorphin-I was antagonized by pretreatment with naltrexone but not by naltrindole, a selective antagonist of delta-opioid receptors. These experiments reveal the localization of mu and delta opioid receptors reached after i.c.v. injection and provide evidence to support the suggestion that delta-opioid receptors contribute little or none to the supraspinal antinociception.
在小鼠脑室内注射碘化的 FK33 - 824 和 [D - Ala2]强啡肽 - I 后,研究了脑阿片受体的体内结合特性。这两种物质在体外分别表现为对 μ 和 δ 受体具有高亲和力的高度选择性配体。脑室内注射后,[125I]FK33 - 824 和 [125I][D - Ala2]强啡肽 - I 表现出相似的扩散动力学,并分别特异性结合到药理学上表征为 μ 和 δ 受体的位点。放射自显影分析显示,脑室内给药后,[125I]FK33 - 824 和 [125I][D - Ala2]强啡肽 - I 在脑室周围的浓度高于脑深部结构,且体内标记的特定位点与体外标记后观察到的不同。在甩尾试验中,FK33 - 824 的镇痛作用比 [D - Ala2]强啡肽 - I 强 250 倍,在产生相似镇痛效果的剂量下,[D - Ala2]强啡肽 - I 占据了高比例的 μ 受体。此外,[D - Ala2]强啡肽 - I 的镇痛作用可被纳曲酮预处理拮抗,但不能被 δ - 阿片受体选择性拮抗剂纳曲吲哚拮抗。这些实验揭示了脑室内注射后脑内 μ 和 δ 阿片受体的定位,并为 δ - 阿片受体对脊髓上抗伤害感受作用很小或无作用这一观点提供了支持证据。